Paydirt
KA
Insider

Karen M. Anderson

Chief People Officer

Karen M. Anderson (Chief People Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $3.2M of CNTA (120,029 sh across 2 lots, as filed), executed Mar 13.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.6M
shares × price, as filed
Last traded
Mar 26
Filed Mar 27

Median ADV $76.8M across their filed names

Open performance→
Volume by month
$9.6M$4.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2024 · sells $184KFeb 2025 · sells $690KMar 2026 · sells $9.6M
Buys $0 Sells $10.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names
CNTA Centessa Pharmaceuticals plc CNTA · 0 buys · 7 sells 7 filings
Recent filings
CNTASALE Centessa Pharmaceuticals plc View filing → $1.2M
41,076 sh × $30.12
Exec Mar 26
Filed Mar 27 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $2.1M
74,811 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 13 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 16 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $581K
30,526 sh × $19.03
Exec Feb 7 2025
Filed Feb 10 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $109K
6,471 sh × $16.86
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $184K
10,624 sh × $17.32
Exec Dec 17 2024
Filed Dec 17 2024 · 5:30 PM ET